Announcements Trials
Browse Landscape

Phase

Phase 2 66Phase 1 39Phase NA 32Phase 1/2 23Phase EARLY_PHASE1 5Phase 4 3Phase 3 3Phase 2/3 1

Status

Not yet recruiting 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Head & Neck 2Dermatologic 2Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Glioblastoma 16Glioma 14Neoplasms 13Breast Neoplasms 13Prostatic Neoplasms 12Brain Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 8Lymphoma, B-Cell 8Pancreatic Neoplasms 7Multiple Myeloma 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Recurrence 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Skin Neoplasms 4Lymphoma 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, Follicular 3Lung Neoplasms 3Colonic Neoplasms 3Astrocytoma 3

Interventions

perflutren 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Sarcoma × 90 days × Clear all
NCT04541108 2026-05-22

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Presage Biosciences

Phase EARLY_PHASE1 Active not recruiting
15 enrolled
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT04634227 2026-05-22

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
30 enrolled
Sarcoma

Bone Neoplasms, Sarcoma

NCT07389525 2026-04-24

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

Indiana University

Phase EARLY_PHASE1 Not yet recruiting
80 enrolled
DermatologicGastrointestinalSarcoma

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT07436364 2026-04-14

Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy

Thomas Jefferson University

Phase EARLY_PHASE1 Recruiting
10 enrolled
Sarcoma

Sarcoma

NCT07459283 2026-03-10

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

FindCure Biosciences (ZhongShan) Co., Ltd.

Phase EARLY_PHASE1 Not yet recruiting
10 enrolled
BreastHead & NeckSarcoma

Breast Neoplasms, Head and Neck Neoplasms, Sarcoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡